GC77065
VK-2019
Also known as 2-(1H-indol-6-yl)-3-[2-[4-(oxan-4-yloxymethyl)phenyl]ethynyl]benzoic acid
VK-2019 is an oral active, selective EBNA1((Epstein-Barr Nuclear Antigen 1) inhibitor and can be used for study of EBV-associated carcinomas
ChemicalCAS2044520-06-9MW451.51FormulaC29H25NO4
- CAS number
- 2044520-06-9
- Molecular weight
- 451.51
- Formula
- C29H25NO4
- Solubility
- DMSO： 100 mg/mL (221·48 mM; Need ultrasonic)
- InChIKey
- VUJZFNSWCNSGDV-UHFFFAOYSA-N
- Catalogue number
- GC77065
- Brand
- GLPBIO
Computed properties PubChem CID 122688582 · XLogP 5.3 · TPSA 71.6 Ų · H-bond donors 2
- XLogP
- 5.3
- TPSA
- 71.6 Ų
- H-bond donors
- 2
- H-bond acceptors
- 4
- Rotatable bonds
- 7
- Heavy atoms
- 34
SMILES C1COCCC1OCC2=CC=C(C=C2)C#CC3=C(C(=CC=C3)C(=O)O)C4=CC5=C(C=C4)C=CN5
Computed descriptors from PubChem (CID 122688582), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il